BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 18823665)

  • 1. Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact.
    Bayliss DA; Barrett PQ
    Trends Pharmacol Sci; 2008 Nov; 29(11):566-75. PubMed ID: 18823665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patents related to therapeutic activation of K(ATP) and K(2P) potassium channels for neuroprotection: ischemic/hypoxic/anoxic injury and general anesthetics.
    Judge SI; Smith PJ
    Expert Opin Ther Pat; 2009 Apr; 19(4):433-60. PubMed ID: 19441925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tandem-pore domain potassium channels are functionally expressed in retinal (Müller) glial cells.
    Skatchkov SN; Eaton MJ; Shuba YM; Kucheryavykh YV; Derst C; Veh RW; Wurm A; Iandiev I; Pannicke T; Bringmann A; Reichenbach A
    Glia; 2006 Feb; 53(3):266-76. PubMed ID: 16265669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuronal background K2P channels: focus on TREK1.
    Honoré E
    Nat Rev Neurosci; 2007 Apr; 8(4):251-61. PubMed ID: 17375039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and functional properties of two-pore-domain potassium channels.
    Lesage F; Lazdunski M
    Am J Physiol Renal Physiol; 2000 Nov; 279(5):F793-801. PubMed ID: 11053038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREK-1 K(+) channels in the cardiovascular system: their significance and potential as a therapeutic target.
    Goonetilleke L; Quayle J
    Cardiovasc Ther; 2012 Feb; 30(1):e23-9. PubMed ID: 20946320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of native rat cerebellar granule cell currents due to background K channel KCNK5 (TASK-2).
    Cotten JF; Zou HL; Liu C; Au JD; Yost CS
    Brain Res Mol Brain Res; 2004 Sep; 128(2):112-20. PubMed ID: 15363886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymodal Mechanism for TWIK-Related K+ Channel Inhibition by Local Anesthetic.
    Pavel MA; Chung HW; Petersen EN; Hansen SB
    Anesth Analg; 2019 Oct; 129(4):973-982. PubMed ID: 31124840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel TASK channels inhibitors derived from dihydropyrrolo[2,1-a]isoquinoline.
    Noriega-Navarro R; Lopez-Charcas O; Hernández-Enríquez B; Reyes-Gutiérrez PE; Martínez R; Landa A; Morán J; Gomora JC; Garcia-Valdes J
    Neuropharmacology; 2014 Apr; 79():28-36. PubMed ID: 24212057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TREK-2 (K2P10.1) and TRESK (K2P18.1) are major background K+ channels in dorsal root ganglion neurons.
    Kang D; Kim D
    Am J Physiol Cell Physiol; 2006 Jul; 291(1):C138-46. PubMed ID: 16495368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lipid-activated two-pore domain K+ channel TREK-1 is resistant to hypoxia: implication for ischaemic neuroprotection.
    Buckler KJ; Honoré E
    J Physiol; 2005 Jan; 562(Pt 1):213-22. PubMed ID: 15498799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenamates and diltiazem modulate lipid-sensitive mechano-gated 2P domain K(+) channels.
    Takahira M; Sakurai M; Sakurada N; Sugiyama K
    Pflugers Arch; 2005 Dec; 451(3):474-8. PubMed ID: 16075240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
    Vivier D; Bennis K; Lesage F; Ducki S
    J Med Chem; 2016 Jun; 59(11):5149-57. PubMed ID: 26588045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amide local anesthetics potently inhibit the human tandem pore domain background K+ channel TASK-2 (KCNK5).
    Kindler CH; Paul M; Zou H; Liu C; Winegar BD; Gray AT; Yost CS
    J Pharmacol Exp Ther; 2003 Jul; 306(1):84-92. PubMed ID: 12660311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K(+) efflux through two-pore domain K(+) channels is required for mouse embryonic development.
    Hur CG; Kim EJ; Cho SK; Cho YW; Yoon SY; Tak HM; Kim CW; Choe C; Han J; Kang D
    Reproduction; 2012 May; 143(5):625-36. PubMed ID: 22419831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic targeting of two-pore-domain potassium (K(2P)) channels in the cardiovascular system.
    Wiedmann F; Schmidt C; Lugenbiel P; Staudacher I; Rahm AK; Seyler C; Schweizer PA; Katus HA; Thomas D
    Clin Sci (Lond); 2016 May; 130(9):643-50. PubMed ID: 26993052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volume regulation of murine T lymphocytes relies on voltage-dependent and two-pore domain potassium channels.
    Bobak N; Bittner S; Andronic J; Hartmann S; Mühlpfordt F; Schneider-Hohendorf T; Wolf K; Schmelter C; Göbel K; Meuth P; Zimmermann H; Döring F; Wischmeyer E; Budde T; Wiendl H; Meuth SG; Sukhorukov VL
    Biochim Biophys Acta; 2011 Aug; 1808(8):2036-44. PubMed ID: 21575593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TREK K2P channels and their role in general anaesthesia and neuroprotection.
    Franks NP; Honoré E
    Trends Pharmacol Sci; 2004 Nov; 25(11):601-8. PubMed ID: 15491783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of K2P5.1 potassium channels in multiple sclerosis.
    Bittner S; Bobak N; Herrmann AM; Göbel K; Meuth P; Höhn KG; Stenner MP; Budde T; Wiendl H; Meuth SG
    Ann Neurol; 2010 Jul; 68(1):58-69. PubMed ID: 20582984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of neuronal two-pore domain potassium-channel modulators.
    Mathie A; Veale EL
    Curr Opin Investig Drugs; 2007 Jul; 8(7):555-62. PubMed ID: 17659475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.